Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

Catch up with the latest from the Mississippi legislative session with our weekly recap from the politics team.

REGENXBIO to receive $110 million upfront, potential milestone payments of up to $700 million and meaningful double- ...

A warning on D.E.I.: The Trump administration on Wednesday threatened tens of thousands of federal employees with “adverse consequences” if they fail to report on colleagues who defy orders to purge ...

Collected here is one piece of advice for writers from 49 different mystery and thriller authors featured in our author spotlight series in 2024, including Tess Amy, Ace Atkins, C.J. Box, Mailan ...

The macaques exposed via the mouth or stomach, however, had limited infection but showed no signs of illness. All the monkeys ...

NewsNation Chief Washington Anchor and On Balance host Leland Vittert was a foreign correspondent for four years in Jerusalem ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now ...

Fifteen-year-old Dominic Henriquez from Prosper, Texas, is bringing hope to boys like him who live with Hunter syndrome, a rare genetic disorder that primarily affects males. Dominic’s journey ...

with positive effects on evidence-based surrogate endpoints and early signs of improved clinical outcomes in participants with Hunter syndrome. This designation will provide Denali with more ...